-
1
المؤلفون: Pancholi, Sunil, Ribas, Ricardo, Simigdala, Nikiana, Schuster, Eugene, Nikitorowicz-Buniak, Joanna, Ressa, Anna, Gao, Qiong, Leal, Mariana Ferreira, Bhamra, Amandeep, Thornhill, Allan, Morisset, Ludivine, Montaudon, Elodie, Sourd, Laura, Fitzpatrick, Martin, Altelaar, Maarten, Johnston, Stephen R, Marangoni, Elisabetta, Dowsett, Mitch, Martin, Lesley-Ann, Afd Biomol.Mass Spect. and Proteomics, Biomolecular Mass Spectrometry and Proteomics
المساهمون: Afd Biomol.Mass Spect. and Proteomics, Biomolecular Mass Spectrometry and Proteomics
المصدر: Oncogene, 39(25), 4781. Nature Publishing Group
Oncogeneمصطلحات موضوعية: 0301 basic medicine, MAPK/ERK pathway, Cancer Research, Fulvestrant/administration & dosage, Pyridines, Nude, Drug Resistance, Cyclin-Dependent Kinase 4/genetics, Drug Resistance, Neoplasm/drug effects, Retinoblastoma Protein, Piperazines, Tamoxifen/administration & dosage, Mice, Breast cancer, 0302 clinical medicine, Neoplasm/drug effects, Antineoplastic Combined Chemotherapy Protocols, Receptors, Kinome, Piperazines/pharmacology, Fulvestrant, Inbred BALB C, Pyridines/pharmacology, Mice, Inbred BALB C, Tumor, Cyclin-Dependent Kinase 6/genetics, biology, Receptors, Estrogen/genetics, Cell cycle, Wee1, Receptors, Estrogen, 030220 oncology & carcinogenesis, MCF-7 Cells, Female, RNA Interference, medicine.drug, Mice, Nude, Breast Neoplasms, Breast Neoplasms/genetics, Palbociclib, Antineoplastic Combined Chemotherapy Protocols/pharmacology, Article, Cell Line, 03 medical and health sciences, Cell Line, Tumor, Genetics, medicine, Animals, Humans, Cancer models, Protein Kinase Inhibitors, Molecular Biology, Retinoblastoma Protein/genetics, Cyclin-Dependent Kinase 4, Estrogen/genetics, Cyclin-Dependent Kinase 6, Xenograft Model Antitumor Assays, Tamoxifen, 030104 developmental biology, Xenograft Model Antitumor Assays/methods, Drug Resistance, Neoplasm, Protein Kinase Inhibitors/pharmacology, biology.protein, Cancer research, TSC2
وصف الملف: application/pdf
-
2
المؤلفون: Ana Bosch, Mikkel G. Terp, Henrik J. Ditzel, Monique F. Hundebøl, Neil Portman, Lene E. Johansen, Kamila Kaminska, Gabriella Honeth, Carla Maria Lourenco Alves, Martin Bak, Odd L. Gammelgaard, Elgene Lim, Martina Tuttolomondo, Sidse Ehmsen
المصدر: Nature Communications
Alves, C L, Ehmsen, S, Terp, M G, Portman, N, Tuttolomondo, M, Gammelgaard, O L, Hundebøl, M F, Kaminska, K, Johansen, L E, Bak, M, Honeth, G, Bosch, A, Lim, E & Ditzel, H J 2021, ' Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer ', Nature Communications, vol. 12, 5112 . https://doi.org/10.1038/s41467-021-25422-9
Nature Communications, Vol 12, Iss 1, Pp 1-15 (2021)مصطلحات موضوعية: Fulvestrant/administration & dosage, endocrine system diseases, medicine.drug_class, Science, General Physics and Astronomy, Breast Neoplasms, Proto-Oncogene Proteins c-akt/genetics, Article, General Biochemistry, Genetics and Molecular Biology, Metastasis, Breast cancer, Breast Neoplasms/drug therapy, Cell Line, Tumor, Medicine, Humans, Molecular Targeted Therapy, neoplasms, Protein kinase B, Fulvestrant, Protein Kinase Inhibitors, Multidisciplinary, integumentary system, business.industry, Protein Kinase Inhibitors/administration & dosage, Endocrine therapy, Cancer, Cyclin-Dependent Kinase 4, General Chemistry, Cyclin-Dependent Kinase 6, Cyclin-Dependent Kinase 6/antagonists & inhibitors, Translational research, medicine.disease, Publisher Correction, Cyclin-Dependent Kinase 4/antagonists & inhibitors, Estrogen, Tumor progression, Drug Resistance, Neoplasm, Cancer research, Disease Progression, Drug Therapy, Combination, Female, biological phenomena, cell phenomena, and immunity, business, Proto-Oncogene Proteins c-akt, medicine.drug
-
3دورية أكاديمية
المؤلفون: Slamon, Dennis J., Neven, Patrick, Chia, Stephen, Fasching, Peter A., De Laurentiis, Michelino, Im, Seock-Ah, Petrakova, Katarina, Bianchi, Giulia V., Esteva, Francisco J., Martin, Miguel, Nusch, Arnd, Sonke, Gabe S., De la Cruz-Merino, Luis, Beck, J. Thaddeus, Pivot, Xavier, Sondhi, Manu, Wang, Yingbo, Chakravartty, Arunava, Rodriguez-Lorenc, Karen, Taran, Tetiana, Jerusalem, Guy
المصدر: The New England journal of medicine, 382 (6), 514-524 (2020)
مصطلحات موضوعية: Aged, Aminopyridines/administration & dosage/adverse effects, Antineoplastic Combined Chemotherapy Protocols/adverse effects/therapeutic use, Breast Neoplasms/drug therapy/mortality, Drug Administration Schedule, Female, Fulvestrant/administration & dosage/adverse effects, Humans, Kaplan-Meier Estimate, Middle Aged, Postmenopause, Progression-Free Survival, Purines/administration & dosage/adverse effects, Receptor, ErbB-2, Receptors, Estrogen, Receptors, Progesterone, oncology, Human health sciences, Oncology, Sciences de la santé humaine, Oncologie
Relation: urn:issn:0028-4793; urn:issn:1533-4406
URL الوصول: https://orbi.uliege.be/handle/2268/245119
-
4
المؤلفون: Catherine Jane Bale, Rachel Butler, S Waters, Angela C. Casbard, Sarah Moon, Andrew Foxley, Ramachandran Venkitaraman, Catrin Cox, Johnathan Joffe, Tracie-Ann Madden, Fouad S Alchami, Margherita Carucci, Robert H. Jones, Chris Twelves, Pavel Bezecny, Sacha J Howell
المصدر: Jones, R, Casbard, A, Carucci, M, Cox, C, Butler, R, Alchami, F, Madden, T-A, Bale, C, Bezecny, P, Joffe, J, Moon, S, Twelves, C, Venkitaraman, R, Waters, S, Foxley, A & Howell, S 2020, ' Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive breast cancer (FAKTION) : a multicentre, randomised, controlled, phase 2 trial ', The Lancet Oncology, vol. 21, no. 3, pp. 345-357 . https://doi.org/10.1016/S1470-2045(19)30817-4
مصطلحات موضوعية: 0301 basic medicine, Fulvestrant/administration & dosage, Drug Resistance, Neoplasm/drug effects, law.invention, 0302 clinical medicine, Randomized controlled trial, law, Antineoplastic Combined Chemotherapy Protocols, Clinical endpoint, Neoplasm Metastasis, Fulvestrant, Aged, 80 and over, Manchester Cancer Research Centre, Aromatase Inhibitors, Hazard ratio, Carcinoma, Ductal, Breast, Middle Aged, Prognosis, Survival Rate, Neoplasm Recurrence, Local/drug therapy, Oncology, Receptors, Estrogen, 030220 oncology & carcinogenesis, Female, Receptors, Estrogen/metabolism, medicine.drug, Adult, medicine.medical_specialty, medicine.drug_class, Breast Neoplasms, Carcinoma, Lobular/drug therapy, Placebo, 03 medical and health sciences, Breast Neoplasms/drug therapy, Double-Blind Method, Internal medicine, medicine, Humans, Neoplasm Invasiveness, Pyrroles, Pyrimidines/administration & dosage, Survival rate, Aged, Salvage Therapy, Aromatase Inhibitors/pharmacology, Intention-to-treat analysis, Aromatase inhibitor, business.industry, Pyrroles/administration & dosage, ResearchInstitutes_Networks_Beacons/mcrc, Carcinoma, Lobular, 030104 developmental biology, Pyrimidines, Carcinoma, Ductal, Breast/drug therapy, Drug Resistance, Neoplasm, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Neoplasm Recurrence, Local, business, Follow-Up Studies
-
5
المصدر: Alves, C M L, Elias, D, Lyng, M B, Bak, M & Ditzel, H 2018, ' SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer ', Breast Cancer Research, vol. 20, 60 . https://doi.org/10.1186/s13058-018-0988-9
Breast Cancer Research : BCR
Breast Cancer Research, Vol 20, Iss 1, Pp 1-12 (2018)مصطلحات موضوعية: 0301 basic medicine, SNAI2, Fulvestrant/administration & dosage, Estrogen receptor, Metastasis, Cell Proliferation/drug effects, 0302 clinical medicine, Snail Family Transcription Factors/genetics, Medicine, Neoplasm Metastasis, Fulvestrant, Estrogen Receptor alpha/genetics, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Epithelial-mesenchymal transition, Metastatic breast cancer, Gene Expression Regulation, Neoplastic, 030220 oncology & carcinogenesis, Antineoplastic Agents, Hormonal/administration & dosage, MCF-7 Cells, Estrogen receptor-positive breast cancer, Female, Epithelial-Mesenchymal Transition/drug effects, Research Article, medicine.drug, Endocrine resistance, Adult, Epithelial-Mesenchymal Transition, Antineoplastic Agents, Hormonal, Breast Neoplasms, Drug Resistance, Neoplasm/genetics, lcsh:RC254-282, 03 medical and health sciences, Breast cancer, Breast Neoplasms/drug therapy, Humans, Cell Proliferation, Aged, business.industry, Estrogen Receptor alpha, Cancer, medicine.disease, Gene Expression Regulation, Neoplastic/genetics, 030104 developmental biology, Drug Resistance, Neoplasm, Cancer cell, Cancer research, Snail Family Transcription Factors, business, Tamoxifen
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec9d7f336d2ff1a7d80a2e5a31621b6d
https://findresearcher.sdu.dk:8443/ws/files/141819899/Alves_et_al_2018_Breast_Cancer_Research.pdf -
6مورد إلكتروني
المؤلفون: Caffa, Irene, Spagnolo, Vanessa, Vernieri, Claudio, Valdemarin, Francesca, Becherini, Pamela, Wei, Min, Brandhorst, Sebastian, Zucal, Chiara, Driehuis, Else, Ferrando, Lorenzo, Piacente, Francesco, Tagliafico, Alberto, Cilli, Michele, Mastracci, Luca, Vellone, Valerio G, Piazza, Silvano, Cremonini, Anna Laura, Gradaschi, Raffaella, Mantero, Carolina, Passalacqua, Mario, Ballestrero, Alberto, Zoppoli, Gabriele, Cea, Michele, Arrighi, Annalisa, Odetti, Patrizio, Monacelli, Fiammetta, Salvadori, Giulia, Cortellino, Salvatore, Clevers, Hans, De Braud, Filippo, Sukkar, Samir G, Provenzani, Alessandro, Longo, Valter D, Nencioni, Alessio
المصدر: Nature vol.583 (2020) nr.7817 p.620-624 [ISSN 0028-0836]
مصطلحات الفهرس: Animals, Biological Factors/blood, Breast Neoplasms/diet therapy, Diet Therapy/methods, Diet, Healthy/methods, Disease Models, Animal, Disease Progression, Drug Resistance, Neoplasm/drug effects, Early Growth Response Protein 1/metabolism, Fasting/physiology, Female, Fulvestrant/administration & dosage, Humans, Insulin/blood, Insulin-Like Growth Factor I/metabolism, Leptin/blood, MCF-7 Cells, Mice, Inbred NOD, Mice, SCID, PTEN Phosphohydrolase/metabolism, Piperazines/administration & dosage, Pyridines/administration & dosage, Receptors, Estrogen, Receptors, Progesterone, Tamoxifen/adverse effects, Xenograft Model Antitumor Assays, Artikel, Article
Find this article in full text from Springer Verlag. 
Full Text via ClinicalKey